MedPath

ETOPOSIDE INJECTION

ETOPOSIDE INJECTION

Approved
DIN Number

02080036

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02080036
AIG Number0114567002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CB01 ETOPOSIDE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ETOPOSIDEActive
Strength: 20 MG / ML
Monograph: ETOPOSIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.